B-cell Malignancies

Showing 1 - 8 of 8

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

B-Cell Malignancies Trial in Canton, Houston (TT-01488)

Recruiting
  • B-Cell Malignancies
  • Canton, Ohio
  • +1 more
Jun 8, 2022

B-cell Malignancies, Colorectal Cancer (CRC), Head Neck Cancer Trial in United Kingdom, United States (Nivolumab (Phase 1),

Completed
  • B-cell Malignancies
  • +7 more
  • Nivolumab (Phase 1)
  • +4 more
  • Birmingham, Alabama
  • +23 more
Aug 26, 2020

B-cell Malignancies, Cancer Trial in Worldwide (MEDI-551, Rituximab)

Completed
  • B-cell Malignancies
  • Cancer
  • Birmingham, Alabama
  • +20 more
Apr 29, 2020

Influenza Vaccine in B-cell Malignancies Treated With Idelalisib

Terminated
  • B-cell Malignancies
  • Influenza Vaccine
  • Prague 10, Czechia
  • +1 more
Feb 18, 2020

B-cell Malignancies Trial in Guangzhou, Shenzhen, Kunming (4SCAR19 and 4SCAR22, 4SCAR19 and 4SCAR38, 4SCAR19 and 4SCAR20)

Unknown status
  • B-cell Malignancies
  • 4SCAR19 and 4SCAR22
  • +5 more
  • Guangzhou, Guangdong, China
  • +3 more
Sep 18, 2019

B-cell Malignancies Trial in Shenzhen, Kunming (Therapeutic 4SCAR19 cells)

Unknown status
  • B-cell Malignancies
  • Therapeutic 4SCAR19 cells
  • Shenzhen, Guangdong, China
  • +1 more
Sep 18, 2019

B-Cell Malignancies Trial (Low dose ET019002- T Cells, Middle dose ET019002- T Cells, High dose ET019002- T Cells)

Unknown status
  • B-Cell Malignancies
  • Low dose ET019002- T Cells
  • +2 more
  • (no location specified)
Aug 22, 2018

B-Cell Malignancies Trial in United States (Urelumab, Rituximab)

Completed
  • B-Cell Malignancies
  • Urelumab
  • Rituximab
  • Los Angeles, California
  • +14 more
Mar 29, 2017